Form D · Other Health Care
Risalto Health Inc.
New York, NY · CIK 0001793126
Offering snapshot reported Nov 12, 2019 · SEC filing
- Reported sold
- $5.35M Offering amount: $8.85M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 28, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2019 | Initial | $5,351,987 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-353182
Includes $1,851,987 of previously issued convertible securities that converted in connection with the offering.
Source: Form D, filed Nov 12, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles Boorady | Director |
| Vince Coppola | Director |
| Benjamin Pizzarello | Director, Executive |
| David Whelan | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
600 5 Th Avenue, 2 Nd Floor
New York, NY, 10020
New York, NY, 10020